Compare Bendeka vs. Bendamustine
Head-to-head comparisons of medication uses, side effects, warnings, and more.
- Bendeka (bendamustine)Bendamustine (Treanda)
- Bendeka (bendamustine)Bendamustine (Treanda)
Summary of Bendeka vs. Bendamustine
Summary for Alkylating agentPrescription onlyBendeka (bendamustine) is a chemotherapy medication that works as an alkylating agent. It treats some blood cancers, like chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Bendeka (bendamustine) is given as an infusion through a vein at a medical center or clinic. It’s given on the first 2 days of each treatment cycle. Side effects include nausea, tiredness, and low blood cell counts. Bendeka (bendamustine) is available as a brand-name medication.
Summary for Alkylating agentPrescription onlyBendamustine (Treanda) is a type of chemotherapy called an alkylating agent. It’s used to treat people with certain blood cancers, including non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Bendamustine (Treanda) is given as an infusion through a vein at a medical center or clinic. It’s usually given on the first 2 days of each treatment cycle. Side effects include nausea, tiredness, and low blood cell counts. Bendamustine (Treanda) is available as a brand-name and generic medication.
Indications of Bendeka vs. Bendamustine
Indications for•Chronic lymphocytic leukemia (CLL)•B-cell non-Hodgkin lymphoma (NHL), after previous treatment with rituximab (Rituxan) within the last 6 monthsIndications for•Chronic lymphocytic leukemia (CLL)•B-cell non-Hodgkin lymphoma (NHL), after previous treatment with rituximab (Rituxan) within the last 6 monthsPros and Cons of Bendeka vs. Bendamustine
Pros and Const for Alkylating agentPros•Given on the first 2 days of each treatment cycle (every 3 or 4 weeks, depending on your type of cancer)•Infusion takes about 10 minutes•Doesn’t typically cause hair lossCons•Must be given as an infusion through a vein at a medical center•Can cause nausea•Raises your risk for infectionsPros and Const for Alkylating agentPros•Given on the first 2 days of each treatment cycle (every 3 or 4 weeks, depending on your type of cancer)•Doesn’t typically cause hair loss•Recommended treatment for non-Hodgkin lymphomaCons•Must be given as an infusion through a vein at a medical center•Often causes nausea•Raises your risk of infectionsCommon Side Effects of Bendeka vs. Bendamustine
Common Side Effects for•Lower white blood cells (up to 99%)•Lower hemoglobin levels (up to 88%)•Lower platelet levels (86%)•Nausea (75%)•Tiredness (57%)•Vomiting (40%)•Diarrhea (37%)•Fever (34%)•Constipation (29%)•Lower appetite (23%)•Cough (22%)•Headache (21%)Common Side Effects for•Lower white blood cells (up to 99%)•Lower hemoglobin levels (up to 88%)•Lower platelet levels (86%)•Nausea (75%)•Tiredness (57%)•Vomiting (40%)•Diarrhea (37%)•Fever (34%)•Constipation (29%)•Lower appetite (23%)•Cough (22%)•Headache (21%)Warnings of Bendeka vs. Bendamustine
Common Side Effects for•Low blood cell counts•Risk of infection•Risk of progressive multifocal leukoencephalopathy•Allergic reactions and infusion reactions•Tumor lysis syndrome•Serious skin reactions•Serious liver problems•Risk of new cancers•Tissue damage around the infusion site•Harm to an unborn babyCommon Side Effects for•Low blood cell counts•Risk of infection•Risk of progressive multifocal leukoencephalopathy•Allergic reactions and infusion reactions•Tumor lysis syndrome•Serious skin reactions•Serious liver problems•Risk of new cancers•Tissue damage around the infusion site•Harm to an unborn babyPrices with our coupons for Bendeka vs. Bendamustine
Browse medications
View AllResearch prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.